John M. Evans - Jun 16, 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, Attorney-in-Fact
Stock symbol
VERV
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
3
Date filed
6/16/2021, 07:37 PM
Previous filing
Sep 21, 2021
Next filing
Jun 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV Stock Option (right to buy) Jun 16, 2021 Common Stock 21.6K $8.98 Direct F1
holding VERV Stock Option (right to buy) Jun 16, 2021 Common Stock 21.6K $2.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 1, 2021 for 21,599 shares. The shares underlying the option vest quarterly over 4 years in 16 equal quarterly installments, with the first installment commencing on April 1, 2021.
F2 The option was granted on September 16, 2020 for 21,599 shares. The shares underlying the option vest quarterly over 3 years in 12 equal quarterly installments, with the first installment commencing on July 1, 2020.

Remarks:

Exhibit Index: 24.1 Power of Attorney